Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Raymond James 42nd Annual Institutional Investors Conference

      Share Article
      share to

      New Brunswick, NJ (February 3, 2021) -- Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2nd. Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 9:10 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately 24-hrs after the live webcast.

      ###

      Press Contacts:
      Christina Chan
      (732) 524-6297

      Investor Contacts:
      Lisa Romanko
      (732) 524-2034

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.